Trinity Biotech (TRIB) Free Cash Flow (2016 - 2024)
Historic Free Cash Flow for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to $3.7 million.
- Trinity Biotech's Free Cash Flow rose 56785.71% to $3.7 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$175683.0, marking a year-over-year increase of 9456.26%. This contributed to the annual value of -$3.8 million for FY2024, which is 6479.45% up from last year.
- Latest data reveals that Trinity Biotech reported Free Cash Flow of $3.7 million as of Q4 2024, which was up 56785.71% from -$3.9 million recorded in Q2 2024.
- Over the past 5 years, Trinity Biotech's Free Cash Flow peaked at $14.8 million during Q4 2020, and registered a low of -$7.1 million during Q2 2023.
- Moreover, its 5-year median value for Free Cash Flow was $560000.0 (2023), whereas its average is $1.7 million.
- In the last 5 years, Trinity Biotech's Free Cash Flow plummeted by 498520139.86% in 2023 and then skyrocketed by 56785.71% in 2024.
- Trinity Biotech's Free Cash Flow (Quarter) stood at $14.8 million in 2020, then tumbled by 69.82% to $4.5 million in 2021, then plummeted by 38.35% to $2.8 million in 2022, then crashed by 79.72% to $560000.0 in 2023, then soared by 567.86% to $3.7 million in 2024.
- Its Free Cash Flow stands at $3.7 million for Q4 2024, versus -$3.9 million for Q2 2024 and -$3317.0 for Q1 2024.